Dr. Reddy’s Announces the Launch of Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets
08:37 EDT 7 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has
launched Montelukast Sodium Tablets (10 mg) and Montelukast Sodium
Chewable Tablets (4 mg & 5 mg), bioequivalent generic versions of
SINGULAIR® Tablets and ...
Other Sources for this Article
Dr. Reddy’s Laboratories Ltd.
Investors and
Financial Analysts:
Kedar Upadhye, +91-40-66834297
kedaru@drreddys.com
or
Saunak
Savla, +91-40-49002135
saunaks@drreddys.com
or
Milan
Kalawadia (USA), +1-908-203-4931
mkalawadia@drreddys.com
or
Media:
S
Rajan, +91-40-49002445
rajans@drreddys.com
More From BioPortfolio on "Dr. Reddy’s Announces the Launch of Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
